These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 14627173)

  • 1. Budesonide/formoterol adjustable maintenance dosing reduces asthma exacerbations versus fixed dosing.
    Ställberg B; Olsson P; Jörgensen LA; Lindarck N; Ekström T
    Int J Clin Pract; 2003 Oct; 57(8):656-61. PubMed ID: 14627173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
    Aalbers R; Backer V; Kava TT; Omenaas ER; Sandström T; Jorup C; Welte T
    Curr Med Res Opin; 2004; 20(2):225-40. PubMed ID: 15006018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of adjustable dosing with budesonide/formoterol on health-related quality of life and asthma control compared with fixed dosing.
    Buhl R; Kardos P; Richter K; Meyer-Sabellek W; Brüggenjürgen B; Willich SN; Vogelmeier C
    Curr Med Res Opin; 2004 Aug; 20(8):1209-20. PubMed ID: 15324523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjustable maintenance dosing with budesonide/formoterol in a single inhaler provides effective asthma symptom control at a lower dose than fixed maintenance dosing.
    Canonica GW; Castellani P; Cazzola M; Fabbri LM; Fogliani V; Mangrella M; Moretti A; Paggiaro P; Sanguinetti CM; Vignola AM;
    Pulm Pharmacol Ther; 2004; 17(4):239-47. PubMed ID: 15219269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and safety of adjustable maintenance dosing with budesonide/formoterol turbuhaler compared with traditional fixed doses in bronchial asthma: a multi-centre Nigerian study.
    Ige OM; Ohaju-Obodo JO; Chukwu C; Peters EJ; Okpapi J; Chukwuka C
    Afr J Med Med Sci; 2010 Sep; 39(3):165-72. PubMed ID: 21416785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with traditional fixed dosing: a five-month multicentre Canadian study.
    FitzGerald JM; Sears MR; Boulet LP; Becker AB; McIvor AR; Ernst P; Smiljanic-Georgijev NM; Lee JS;
    Can Respir J; 2003; 10(8):427-34. PubMed ID: 14679407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients.
    Busse WW; Shah SR; Somerville L; Parasuraman B; Martin P; Goldman M
    J Allergy Clin Immunol; 2008 Jun; 121(6):1407-14, 1414.e1-6. PubMed ID: 18455221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma.
    Ställberg B; Ekström T; Neij F; Olsson P; Skoogh BE; Wennergren G; Löfdahl CG;
    Respir Med; 2008 Oct; 102(10):1360-70. PubMed ID: 18723335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic assessment of adjustable maintenance treatment with budesonide/formoterol in a single inhaler versus fixed treatment in asthma.
    Brüggenjürgen B; Selim D; Kardos P; Richter K; Vogelmeier C; Roll S; Meyer-Sabellek W; Buhl R; Willich SN
    Pharmacoeconomics; 2005; 23(7):723-31. PubMed ID: 15987228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
    Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C
    Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An economic evaluation of adjustable and fixed dosing with budesonide/formoterol via a single inhaler in asthma patients: the ASSURE study.
    Price D; Haughney J; Lloyd A; Hutchinson J; Plumb J
    Curr Med Res Opin; 2004 Oct; 20(10):1671-9. PubMed ID: 15462701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
    Bousquet J; Boulet LP; Peters MJ; Magnussen H; Quiralte J; Martinez-Aguilar NE; Carlsheimer A
    Respir Med; 2007 Dec; 101(12):2437-46. PubMed ID: 17905575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An individualized, adjustable maintenance regimen of budesonide/formoterol provides effective asthma symptom control at a lower overall dose than fixed dosing.
    Leuppi JD; Salzberg M; Meyer L; Bucher SE; Nief M; Brutsche MH; Tamm M
    Swiss Med Wkly; 2003 May; 133(21-22):302-9. PubMed ID: 12861468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjustable maintenance dosing with budesonide/formoterol or budesonide: double-blind study.
    Pohl WR; Vetter N; Zwick H; Hrubos W
    Respir Med; 2006 Mar; 100(3):551-60. PubMed ID: 16005623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
    O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M
    J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma.
    Kuna P; Creemers JP; Vondra V; Black PN; Lindqvist A; Nihlen U; Vogelmeier C
    Respir Med; 2006 Dec; 100(12):2151-9. PubMed ID: 16701989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Budesonide/formoterol maintenance and reliever therapy versus conventional best standard treatment in asthma in an attempted 'real life' setting.
    Søes-Petersen U; Kava T; Dahle R; Lei Y; Dam N
    Clin Respir J; 2011 Jul; 5(3):173-82. PubMed ID: 21679353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study.
    Lundborg M; Wille S; Bjermer L; Tilling B; Lundgren M; Telg G; Ekström T; Selroos O
    Curr Med Res Opin; 2006 May; 22(5):809-21. PubMed ID: 16709303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjustable and fixed dosing with budesonide/ formoterol via a single inhaler in asthma patients: the ASSURE study.
    Ind PW; Haughney J; Price D; Rosen JP; Kennelly J
    Respir Med; 2004 May; 98(5):464-75. PubMed ID: 15139576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.